Alzheimer Europe contributes to the MIRIADE training week for Early-Stage Researchers

21/10/2021

MIRIADE is a Horizon 2020-funded, Marie Sklodowska-Curie Innovative Training Network (ITN), which aims to train a new generation of scientists able to optimise and accelerate development of novel biomarkers for dementia. As well as undertaking laboratory-based, in silico and clinical research on biomarkers for different types of dementia, early-stage researchers (ESRs) that are working on MIRIADE also receive training on a range of academic and transferable skills, aiming to prepare them for future careers as biomarker researchers.

As part of the Autumn 2021 MIRIADE training week, Alzheimer Europe organised two sessions on communication, dissemination, ethics and privacy regulations. First, Chris Bintener (Project Communications Officer) held an interactive session on communication and dissemination, describing some of the communication channels that Alzheimer Europe uses for outreach and external engagement. He then moderated discussions on science communication activities with the ESRs, answering questions about how to maximise engagement with different stakeholders, and explaining how various platforms can be leveraged to reach different audiences. Next, Angela Bradshaw (Project Officer) delivered a session on ethics and data protection, first outlining the fundamental principles of biomedical ethics before moving on to the General Data Protection Regulation, how it might apply to research being carried out as part of MIRIADE, and how ESRs can ensure data privacy in their work. Find out more about MIRIADE:

https://miriade.eu/